Biosensors & continuous monitoring

sensors Low 6 min
verified 24 Jun 2026 valid until confidence HIGH 43 sources
fda ema

01Overview and value chain

Markers: [EC: GMP Annex 1 | OECD: Industrial biotechnology | Regulator: FDA (USA), EMA (EU)]

Biosensors and continuous monitoring systems are the foundation of modern biomanufacturing, enabling Process Analytical Technology (PAT) to transition from theoretical frameworks to everyday industrial reality. These advanced sensors replace slow, contamination-prone manual sampling with real-time, inline data streams. By utilizing radio-frequency impedance to measure viable cell volume or advanced optical fluorescence to track dissolved oxygen and pH, these systems deliver millisecond-resolution telemetry. Implementation of these continuous monitoring networks typically increases bioreactor yields by 15–30% and reduces batch failure rates by over 50%, while ensuring strict compliance with FDA/EMA cGMP continuous manufacturing guidelines.

The key directions of biosensors and continuous monitoring are:

  1. Viable Biomass Monitoring (Capacitance probes): Utilizing radio-frequency impedance to exclusively measure living cells with intact membranes, ignoring dead cells and gas bubbles.
  2. Optical and Non-Invasive Sensors (Optical probes): Employing fluorescent chemical complexes that react to specific molecules (like O2 or CO2) without consuming the analyte, enabling highly stable, drift-free long-term readings.
  3. Continuous Metabolite Analysis (In-situ metabolite sensors): Tracking critical nutrients and byproducts like glucose and lactate in real time to enable dynamic, automated feeding strategies.
  4. Inline Mass Spectrometry (Spectrometry): Deploying miniaturized, rugged mass spectrometers directly to the bioreactor exhaust or liquid phase for multiplexed, real-time chemical profiling.

Sectoral value chain

Value chain levels

LevelDescriptionKey inputs/outputs
Sensor Discovery & EngineeringDeveloping new sensor modalities, such as novel fluorescent dyes or miniaturized spectrometers.In: R&D, advanced materials.
Out: Sensor prototypes.
Calibration & ManufacturingProducing sensors under strict ISO standards, ensuring batch-to-batch consistency and sterility.In: Components, calibration gas/fluid.
Out: Finished sterile sensors.
Bioreactor IntegrationInstalling probes via standard ports (e.g., Pg13.5) into stainless steel or single-use bioreactors.In: Sensors, bioreactors.
Out: Monitored culture vessels.
Data Acquisition & PATTransmitting analog or digital signals (e.g., Arc, Modbus) to central supervisory systems (SCADA).In: Raw electrical signals.
Out: Normalized data streams.
Feedback & Auto-FeedingUsing continuous data to trigger automated pumps for pH adjustment, defoaming, or nutrient dosing.In: Live data, control logic.
Out: Maintained homeostatic parameters.
Automated Quality ControlValidating that the entire batch remained within the designated design space, enabling real-time release.In: Full batch telemetry.
Out: GMP release documentation.

Cross-cutting technologies of the sector:

  • Single-use sensor integration: Pre-calibrated, gamma-irradiated optical sensor patches permanently welded into single-use bioprocessing bags.
  • Digital smart sensors: Probes with integrated microprocessors that store their own calibration data and health status, transmitting robust digital signals rather than fragile analog currents.
  • Spectroscopic data modeling: Advanced chemometric algorithms that translate complex Raman or mass spectra into actionable glucose, lactate, and titer concentrations.

02US

The United States leads the development of next-generation analytical modalities, particularly pushing the boundaries of spectrometry and intelligent digital probes.

Digital probes, mass spectrometry, continuous manufacturing

  • Intelligent sensor dominance: US-based engineering hubs for companies like Hamilton push the adoption of smart digital sensors that eliminate external transmitters, streamlining biomanufacturing facility footprints.
  • Advanced analytics: Startups and established tech firms (e.g., Atonarp, YSI) are deploying highly sophisticated inline mass spectrometry and biochemistry analyzers to provide unprecedented chemical visibility.
  • FDA PAT initiatives: Regulatory encouragement from the FDA’s Emerging Technology Team drives US biopharma to aggressively adopt continuous monitoring to enable real-time batch release.

03CN

China is rapidly indigenizing bioprocess sensor technology to secure its massive, growing biomanufacturing capacity against geopolitical supply chain risks.

Import substitution, mass biomanufacturing, cost optimization

  • Domestic engineering: Companies like Applitech are rapidly developing domestic alternatives for bioreactor controls and sensors, historically dominated by European and US players.
  • Scale-up focus: As China builds out vast new capacities for monoclonal antibodies and CDMO services, the demand for cost-effective, reliable continuous monitoring systems is skyrocketing.
  • Single-use adoption: The fast transition of Chinese biopharma to single-use technologies is accelerating the local integration of disposable optical sensors.

04EU

The European Union remains the historical and current powerhouse of precision instrumentation, engineering the vast majority of the world’s gold-standard bioprocess probes.

Precision engineering, optical sensors, biomass capacitance

  • Swiss & German precision: Industry titans like Mettler Toledo and PreSens dominate the global market for robust, highly accurate pH, DO, and optical sensors.
  • Biomass capacitance pioneers: UK-based Aber Instruments effectively established the global standard for radio-frequency impedance monitoring of viable biomass.
  • Single-use innovation: EU manufacturers are at the forefront of developing single-use-compatible sensors, solving the complex engineering challenges of gamma-sterilization stability.

05Leading companies and research institutes

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Mettler Toledo🇨🇭 SwitzerlandIngold sensorsInline analytical precisioncommercial
Hamilton Company🇺🇸 USAArc intelligent sensorsIntegrated microprocessorscommercial
PreSens🇩🇪 GermanyOptical sensor patchesNon-invasive fluorescencecommercial
Aber Instruments🇬🇧 UKFutura biomass probesRF impedance trackingcommercial
Atonarp🇺🇸 USAASTON mass spectrometryInline molecular profilingcommercial
C-CIT Sensors🇨🇭 SwitzerlandCITSens BioIn-situ metabolite trackingcommercial

06Tech stack and innovations

The transition from offline sampling to continuous inline monitoring requires sensor technologies capable of withstanding harsh sterilization while providing drift-free telemetry.

  1. Radio-Frequency Impedance (Capacitance):
    • Applies an alternating electrical field to the cell culture. Intact cell membranes polarize, acting as tiny capacitors.
    • Measures only viable biomass, completely ignoring dead cells, cell debris, and gas bubbles, providing a true reflection of culture health.
  2. Phase Fluorometry (Optical DO/pH):
    • Utilizes a chemical dye immobilized on a sensor tip. Blue or green light excites the dye, which emits red light.
    • The phase shift (delay) of the emitted light is perfectly inversely proportional to the concentration of oxygen or pH, unaffected by flow rate or electrical interference.
  3. Inline Mass Spectrometry:
    • Miniaturized quadrupole or magnetic sector spectrometers directly sample the bioreactor off-gas or liquid phase.
    • Capable of simultaneously tracking oxygen uptake rate (OUR), carbon dioxide evolution rate (CER), and volatile metabolites with parts-per-billion sensitivity.

07Value chains and production pipelines

Industrial pipeline of Bioprocess Continuous Monitoring (ISO 9001)

Stage 1: Sensor sterilization

Sensors are prepared for the bioprocess environment. Reusable stainless-steel probes undergo harsh steam-in-place (SIP) or autoclave cycles at 121°C, while single-use optical patches are pre-installed in bags and subjected to gamma irradiation.

Stage 2: Bioreactor integration

The sterilized probes are electronically connected to the bioreactor control tower. Digital “smart” probes perform an automatic self-diagnostic check and upload their internal calibration history to the controller.

Stage 3: Signal acquisition

As the cell culture grows, the sensors continuously monitor the broth. Capacitance probes emit RF fields, while optical sensors flash excitation LEDs, capturing thousands of raw data points per minute.

Stage 4: Data normalization

Integrated microprocessors or external transmitters filter out background noise, adjust for temperature fluctuations, and translate raw electrical or optical signals into standardized metrics (e.g., mg/L, pH, pF/cm).

Stage 5: Automated feedback

The normalized data is fed into the bioreactor’s SCADA (Supervisory Control and Data Acquisition) system. When parameters deviate from the setpoint, the system automatically triggers PID-controlled actions, such as sparging pure oxygen or pumping base solution.

Stage 6: Batch validation

At the conclusion of the fermentation run, the unbroken, cryptographically secure continuous data log is compiled. This comprehensive digital twin of the batch proves that the culture remained within the GMP design space, enabling rapid quality release.

SupplierPriceLead timeCertificatesRiskConfidence
Hamilton CompanypremiumcustomCommercial Inline SensorsLowHIGH
Mettler ToledopremiumcustomCommercial AnalyticalLowHIGH
PreSenscustomon requestCommercial Optical SensorsLowHIGH
Aber InstrumentspremiumcustomCommercial Biomass ProbesLowHIGH
AtonarppremiumcustomCommercial SpectrometryMediumHIGH
C-CIT Sensorscustomon requestCommercial MetaboliteMediumHIGH
AI Recommendation The FDA’s push for continuous manufacturing and real-time release testing is driving rapid adoption of inline bioprocess sensors. Traditional optical pH and DO probes remain the gold standard, but the market is rapidly integrating radio-frequency impedance for viable cell mass and miniaturized mass spectrometry for real-time metabolite tracking, shifting biomanufacturing from post-batch QA to predictive, dynamic control.
Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.